Many people with type 2 diabetes must resort to insulin injections when widely prescribed drugs known as sulfonylureas lose their effectiveness and an individual’s blood sugar levels rise. Now, a team of researchers reports that many of these individuals possess a genetic variation that may predispose them to having these drugs fail.
